BioSpace News Archive

Drug Development

EUA of AstraZeneca’s Pre-Exposure Therapy Offers Hope for Immunocompromised

The FDA has approved emergency use authorization for AstraZeneca’s Evusheld cocktail as prophylaxis against COVID-19 infection in adults and adolescents aged at least 12 years.

December 9, 2021
·
2 min read
·
Vanessa Doctor, RN
FDA

Reata Stock Takes a Blow as FDA Panel Voted Down Alport Syndrome Drug

Shares of Reata Pharmaceuticals have plunged nearly 40% in premarket trading after an FDA advisory panel recommended against the approval of its Alport syndrome disease treatment, bardoxolone.

December 9, 2021
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Dec. 10

As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.

December 9, 2021
·
8 min read
·
Alex Keown
Business

1E Therapeutics Raises $120 Million in Seed Funding

1E Therapeutics announced $120 million seed funding, a remarkable feat for an early-stage biotech company. The funding is the largest of its kind for an Israeli biotech company.

December 9, 2021
·
2 min read
·
Alvin Clavines
CSL and uniQure’s Hemophilia B Gene Therapy Hits the Mark

CSL Behring and uniQure announced that their etranacogene dezaparvovec hit the pre-specified primary endpoint in their Phase III clinical trial in severe to moderately severe hemophilia B.

December 9, 2021
·
3 min read
·
Mark Terry
North America Unit Dose Manufacturing Market Expected Rise at a Noticeable Speed in the Upcoming Years | TMR Research Study

The North America unit dose manufacturing market is expected to rise at a noticeable speed in the upcoming years.

December 9, 2021
·
4 min read
Interactive Patient Engagement Solutions Market Study Offering Deep Insight Related to Growth Trends Until 2031

The penetration of healthcare IT in patient care has underpinned the steady evolution of patient engagement with the health systems world over.

December 9, 2021
·
5 min read
Hyperphosphatemia Treatment Market: Rise in incidence of end-stage renal disease incidence to drive the market

Continuous studies have been made on the pathophysiology of hyperphosphatemia, evaluation of therapies on the clinical outcomes, and guidelines have shaped the evidence underlying current and emerging treatment options.

December 9, 2021
·
6 min read
North America Healthcare ERP Consulting Services Market predicted to hold a Noticeable Share in the Industry Revenue

The healthcare ERP consulting services market has been anticipated to grow at a noticeable pace during the forecast period.

December 9, 2021
·
4 min read
SDS Poly Acrylamide Gel Electrophoresis Market: Advancements in the Field of Chemical Testing and Research Fuel the Growth of the Global Market

The global SDS poly acrylamide gel electrophoresis market is driven primarily by advancements in the field of molecular biology.

December 9, 2021
·
4 min read